• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 患者一年内白细胞介素-6、肿瘤坏死因子-α和 C-反应蛋白的可重复性。

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.

机构信息

North West Lung Research Centre, University of Manchester, South Manchester University Hospitals Trust, Wythenshawe, Manchester, UK.

出版信息

Int J Chron Obstruct Pulmon Dis. 2009;4:149-56. doi: 10.2147/copd.s5018. Epub 2009 Apr 15.

DOI:10.2147/copd.s5018
PMID:19436686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2672790/
Abstract

BACKGROUND

Many of the systemic manifestations of chronic obstructive pulmonary disease (COPD) are mediated through increased systemic levels of inflammatory proteins. We assessed the long term repeatability of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and C-reactive protein (CRP) over one year and examined the relationships between these systemic markers in COPD.

METHODS

Fifty-eight stable COPD patients completed a baseline and one-year visit. Serum IL-6, plasma CRP, and plasma TNF-alpha were measured. Repeatability was expressed by intraclass correlation coefficient (R(i)) and the Bland-Altman method. Pearson correlations were used to determine the relationships between the systemic markers at both visits.

RESULTS

There was moderate repeatability with a very high degree of statistical significance (p <or= 0.001) between the two visits for all the systemic biomarkers (IL-6, CRP, and TNF-alpha). CRP was significantly associated with IL-6 at both visits (r = 0.55, p = 0.0001, r = 0.51, p = 0.0002, respectively). There were no other significant associations between the systemic markers at either of the visits.

CONCLUSIONS

Systemic inflammatory biomarkers IL-6, CRP, and TNF-alpha were moderately repeatable over a twelve month period in COPD patients. We have also shown that a robust and repeatable association between IL-6 and CRP exists.

摘要

背景

慢性阻塞性肺疾病(COPD)的许多全身表现是通过增加全身炎症蛋白水平来介导的。我们评估了白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)和 C 反应蛋白(CRP)在一年中的长期可重复性,并检查了 COPD 中这些全身标志物之间的关系。

方法

58 例稳定期 COPD 患者完成了基线和一年期就诊。测量血清 IL-6、血浆 CRP 和血浆 TNF-α。用组内相关系数(R(i))和 Bland-Altman 法表示重复性。Pearson 相关用于确定两次就诊时全身标志物之间的关系。

结果

所有全身生物标志物(IL-6、CRP 和 TNF-α)在两次就诊之间均具有中度重复性,具有非常高的统计学意义(p <or= 0.001)。CRP 在两次就诊时均与 IL-6 显著相关(r = 0.55,p = 0.0001,r = 0.51,p = 0.0002)。在两次就诊时,全身标志物之间没有其他显著相关性。

结论

COPD 患者全身炎症生物标志物 IL-6、CRP 和 TNF-α在 12 个月期间具有中度可重复性。我们还表明,IL-6 和 CRP 之间存在强大且可重复的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/71ff89addda1/copd-4-149f3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/53546789583c/copd-4-149f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/09caacb745ed/copd-4-149f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/84e95df31619/copd-4-149f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/71ff89addda1/copd-4-149f3b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/53546789583c/copd-4-149f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/09caacb745ed/copd-4-149f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/84e95df31619/copd-4-149f3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71ce/2672790/71ff89addda1/copd-4-149f3b.jpg

相似文献

1
The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.COPD 患者一年内白细胞介素-6、肿瘤坏死因子-α和 C-反应蛋白的可重复性。
Int J Chron Obstruct Pulmon Dis. 2009;4:149-56. doi: 10.2147/copd.s5018. Epub 2009 Apr 15.
2
Systemic inflammation in patients with COPD and pulmonary hypertension.慢性阻塞性肺疾病(COPD)合并肺动脉高压患者的全身炎症
Chest. 2006 Aug;130(2):326-33. doi: 10.1378/chest.130.2.326.
3
Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.慢性阻塞性肺疾病稳定期和加重期全身炎症的生物标志物
Lung. 2008 Nov-Dec;186(6):403-9. doi: 10.1007/s00408-008-9106-6. Epub 2008 Sep 20.
4
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.C反应蛋白作为稳定期慢性阻塞性肺疾病全身炎症标志物的价值
Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.
5
Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.在稳定期慢性阻塞性肺疾病(COPD)中,I型胶原周转指标的血清水平发生改变,同时伴有白细胞介素-6(IL-6)和白细胞介素-8(IL-8)的释放。
Int J Chron Obstruct Pulmon Dis. 2019 Jan 3;14:163-168. doi: 10.2147/COPD.S188139. eCollection 2019.
6
Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.慢性阻塞性肺疾病组间炎症生物标志物的比较:一项横断面研究。
Niger J Clin Pract. 2020 Jun;23(6):817-824. doi: 10.4103/njcp.njcp_222_19.
7
Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.血清TRAIL和DR5水平升高与稳定期慢性阻塞性肺疾病(COPD)患者的肺功能及炎症相关。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 6;10:2405-12. doi: 10.2147/COPD.S92260. eCollection 2015.
8
Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.稳定期慢性阻塞性肺疾病(COPD)患者全身炎症标志物、外周肌肉质量与肢体肌肉力量之间的关系。
Int J Chron Obstruct Pulmon Dis. 2015 Aug 6;10:1553-8. doi: 10.2147/COPD.S85954. eCollection 2015.
9
Associations between BODE index and systemic inflammatory biomarkers in COPD.COPD 患者 BODE 指数与系统性炎症生物标志物的相关性研究。
COPD. 2011 Dec;8(6):408-13. doi: 10.3109/15412555.2011.619599.
10
Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.哮喘-慢性阻塞性肺疾病重叠综合征中Th2与非Th2混合性炎症模式:一种网络分析方法
Int J Chron Obstruct Pulmon Dis. 2018 Feb 12;13:591-601. doi: 10.2147/COPD.S153694. eCollection 2018.

引用本文的文献

1
Correlation between serum bilirubin, blood uric acid, and C-reactive protein and the severity of chronic obstructive pulmonary disease.血清胆红素、血尿酸与 C-反应蛋白与慢性阻塞性肺疾病严重程度的相关性。
J Health Popul Nutr. 2024 Jul 8;43(1):105. doi: 10.1186/s41043-024-00593-5.
2
The Molecular Blueprint for Chronic Obstructive Pulmonary Disease (COPD): A New Paradigm for Diagnosis and Therapeutics.慢性阻塞性肺疾病(COPD)的分子蓝图:诊断和治疗的新模式。
Oxid Med Cell Longev. 2023 Dec 21;2023:2297559. doi: 10.1155/2023/2297559. eCollection 2023.
3
Changes in systemic inflammation after pulmonary rehabilitation in patients with COPD and severe physical inactivity - an exploratory study.

本文引用的文献

1
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.呼出一氧化氮、全身炎症与重度慢性阻塞性肺疾病患者对吸入丙酸氟替卡松的肺量计反应:一项前瞻性研究
Ther Adv Respir Dis. 2008 Apr;2(2):55-64. doi: 10.1177/1753465808088902.
2
Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.慢性阻塞性肺疾病稳定期和加重期全身炎症的生物标志物
Lung. 2008 Nov-Dec;186(6):403-9. doi: 10.1007/s00408-008-9106-6. Epub 2008 Sep 20.
3
Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
慢性阻塞性肺疾病合并严重体力活动不足患者肺康复后全身炎症的变化 - 一项探索性研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221112439. doi: 10.1177/14799731221112439.
4
Tocotrienols: Dietary Supplements for Chronic Obstructive Pulmonary Disease.生育三烯酚:慢性阻塞性肺疾病的膳食补充剂
Antioxidants (Basel). 2021 May 31;10(6):883. doi: 10.3390/antiox10060883.
5
GTS-21, an α7nAChR agonist, suppressed the production of key inflammatory mediators by PBMCs that are elevated in COPD patients and associated with impaired lung function.GTS-21,一种α7nAChR 激动剂,抑制了 COPD 患者中升高的、与肺功能受损相关的 PBMC 关键炎症介质的产生。
Immunobiology. 2020 May;225(3):151950. doi: 10.1016/j.imbio.2020.151950. Epub 2020 May 1.
6
Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV for COPD in Chinese Population: A Prospective Cohort Study.炎症生物标志物联合FEV快速下降对中国人群慢性阻塞性肺疾病的预测价值:一项前瞻性队列研究
Int J Chron Obstruct Pulmon Dis. 2019 Dec 5;14:2825-2833. doi: 10.2147/COPD.S223869. eCollection 2019.
7
Serum inflammatory markers and nutritional status in patients with stable chronic obstructive pulmonary disease.稳定期慢性阻塞性肺疾病患者的血清炎症标志物与营养状况
Lung India. 2019 Sep-Oct;36(5):393-398. doi: 10.4103/lungindia.lungindia_494_18.
8
Association of Adiponectin with Lung Function Impairment and Disease Severity in Chronic Obstructive Pulmonary Disease.脂联素与慢性阻塞性肺疾病肺功能损害及疾病严重程度的关联
Int J Appl Basic Med Res. 2018 Jan-Mar;8(1):14-18. doi: 10.4103/ijabmr.IJABMR_65_17.
9
Tristetraprolin Down-Regulation Contributes to Persistent TNF-Alpha Expression Induced by Cigarette Smoke Extract through a Post-Transcriptional Mechanism.锌指蛋白36通过转录后机制下调导致香烟烟雾提取物诱导肿瘤坏死因子-α持续表达。
PLoS One. 2016 Dec 2;11(12):e0167451. doi: 10.1371/journal.pone.0167451. eCollection 2016.
10
Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients.血清白细胞介素6、白蛋白和C反应蛋白在慢性阻塞性肺疾病患者中的作用
Tanaffos. 2015;14(2):134-40.
C反应蛋白和白细胞介素-6作为接受普伐他汀治疗的慢性阻塞性肺疾病患者预后预测指标的有用性。
Am J Cardiol. 2008 Feb 15;101(4):530-5. doi: 10.1016/j.amjcard.2007.09.102. Epub 2007 Dec 26.
4
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.氟替卡松联合或不联合沙美特罗对慢性阻塞性肺疾病全身炎症生物标志物的影响。
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1207-14. doi: 10.1164/rccm.200709-1356OC. Epub 2008 Feb 28.
5
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.C反应蛋白作为稳定期慢性阻塞性肺疾病全身炎症标志物的价值
Eur J Intern Med. 2008 Mar;19(2):104-8. doi: 10.1016/j.ejim.2007.04.026.
6
Systemic inflammation in chronic obstructive pulmonary disease and asthma: Similarities and differences.慢性阻塞性肺疾病和哮喘中的全身炎症:异同点
Respirology. 2008 Jan;13(1):128-33. doi: 10.1111/j.1440-1843.2007.01170.x.
7
Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.稳定期慢性阻塞性肺疾病合并支气管炎患者炎症标志物之间的相互关系:患者内和患者间的变异性
Thorax. 2008 Jun;63(6):493-9. doi: 10.1136/thx.2007.086751. Epub 2007 Dec 5.
8
Repeatability of inflammatory parameters in induced sputum of COPD patients.慢性阻塞性肺疾病患者诱导痰中炎症参数的重复性
COPD. 2007 Dec;4(4):321-9. doi: 10.1080/15412550701597720.
9
The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)中炎症标志物与残疾之间的关系。
Prim Care Respir J. 2007 Aug;16(4):236-40. doi: 10.3132/pcrj.2007.00047.
10
C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease.C反应蛋白作为慢性阻塞性肺疾病预后的预测指标
Am J Respir Crit Care Med. 2007 Feb 1;175(3):250-5. doi: 10.1164/rccm.200605-713OC. Epub 2006 Oct 19.